Abstract
To evaluate the impact of an antimicrobial stewardship programme (ASP) on reducing broad-spectrum antibiotic use and its effect on carbapenem-resistant Acinetobacter baumannii (CRAb) in hospitalized patients. The study was a retrospective, ecological assessment in a tertiary teaching hospital over 6 years (January 2014 to December 2019). The intervention involved the implementation of an ASP in February 2018, which remains in effect today. This ASP consists of several components, including education, antibiotic guidelines, antibiotic restriction policy with prior approval, audit of compliance to the restriction policy and feedback. Restricted antibiotics were imipenem/cilastatin, ertapenem, meropenem, vancomycin, teicoplanin, tigecycline, colistin, amikacin, piperacillin/tazobactam, levofloxacin and ciprofloxacin. The intervention was evaluated by time-series methods. Statistically significant decreases in the level of antibiotic use, after the introduction of the ASP, were observed for the following antibiotics: imipenem/cilastatin (P = 0.0008), all carbapenems (P = 0.0001), vancomycin (P = 0.0006), colistin (P = 0.0016) and third-generation cephalosporins (P = 0.0004). A statistically significant decrease in the slope, after ...Continue Reading
References
Mar 16, 2000·International Journal of Antimicrobial Agents·J M López-LozanoM Saez
Aug 14, 2002·Journal of Clinical Pharmacy and Therapeutics·A K WagnerD Ross-Degnan
Oct 22, 2004·Emerging Infectious Diseases·Dominique L MonnetIan M Gould
Dec 4, 2004·Nature Medicine·Stuart B Levy, Bonnie Marshall
Oct 20, 2005·The Cochrane Database of Systematic Reviews·P DaveyP Wiffen
Feb 20, 2007·The Journal of Antimicrobial Chemotherapy·Anastasia AntoniadouHelen Giamarellou
Sep 1, 2007·The Journal of Antimicrobial Chemotherapy·Kwan Soo KoJae-Hoon Song
May 10, 2008·The Journal of Antimicrobial Chemotherapy·Mamoon A AldeyabJames C McElnay
Jul 16, 2008·Clinical Microbiology Reviews·Anton Y PelegDavid L Paterson
Mar 18, 2009·Antimicrobial Agents and Chemotherapy·Mamoon A AldeyabJames C McElnay
Apr 12, 2011·The Lancet Infectious Diseases·Timothy R WalshMark A Toleman
Jul 29, 2011·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·A-P MagiorakosD L Monnet
Sep 24, 2011·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·F KontopidouH Giamarellou
Dec 14, 2011·British Journal of Clinical Pharmacology·Mamoon A AldeyabJames C McElnay
Mar 16, 2012·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·UNKNOWN Society for Healthcare Epidemiology of AmericaUNKNOWN Pediatric Infectious Diseases Society
May 15, 2012·American Journal of Infection Control·Anurag N MalaniBonita Singal
May 17, 2012·BMJ : British Medical Journal·Martin Cormican, Akke Vellinga
Oct 2, 2012·The Journal of Antimicrobial Chemotherapy·Diane Ashiru-OredopeUNKNOWN ARHAI Antimicrobial Stewardship Group
May 2, 2013·The Cochrane Database of Systematic Reviews·Peter DaveyMark Wilcox
Jun 15, 2013·The Journal of Antimicrobial Chemotherapy·David M LivermoreNeil Woodford
Nov 21, 2013·The Lancet Infectious Diseases·Ramanan LaxminarayanOtto Cars
Mar 29, 2014·Upsala Journal of Medical Sciences·Göran Tomson, Ioana Vlad
Jul 16, 2014·The Lancet Infectious Diseases·Thomas P Van BoeckelRamanan Laxminarayan
Sep 29, 2015·The Lancet Infectious Diseases·Timothy LawesIan M Gould
Nov 9, 2016·The Lancet Infectious Diseases·Timothy LawesIan M Gould
Dec 16, 2016·Clinical Microbiology Reviews·Darren WongBrad Spellberg
Jul 18, 2017·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·J A CoxG Levy Hara
Dec 26, 2017·The Lancet Infectious Diseases·Evelina TacconelliUNKNOWN WHO Pathogens Priority List Working Group
Apr 27, 2018·Bulletin of the World Health Organization·Christophe Van DijckJanneke Arnoldine Cox
Oct 17, 2018·Antimicrobial Agents and Chemotherapy·Burcu IslerDavid L Paterson
Nov 22, 2018·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·Diamantis PlachourasUNKNOWN The Point Prevalence Survey Study Group
Dec 19, 2018·Emerging Infectious Diseases·Geraldine Mary Conlon-BinghamJames McElnay
Jan 23, 2019·Journal of Global Antimicrobial Resistance·Chukwuma David UmeokonkwoRobinson Onoh
Feb 26, 2019·Antimicrobial Resistance and Infection Control·Dilip NathwaniClaudie Charbonneau
Apr 10, 2019·Nature Microbiology·José-María López-LozanoUNKNOWN THRESHOLDS study group
Nov 6, 2020·The Journal of Antimicrobial Chemotherapy·Wail A HayajnehMamoon A Aldeyab
Citations
Nov 6, 2020·The Journal of Antimicrobial Chemotherapy·Wail A HayajnehMamoon A Aldeyab
Apr 7, 2021·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Dawood YusefMamoon A Aldeyab
Jul 3, 2021·Antibiotics·Sayer Al-AzzamMamoon A Aldeyab
Aug 7, 2021·Antibiotics·Reema A KarasnehMamoon A Aldeyab
Aug 20, 2021·Infection and Drug Resistance·Lewei XieXinhong Guo
Aug 28, 2021·Antibiotics·Reema A KarasnehMamoon A Aldeyab
Oct 2, 2021·Respirology : Official Journal of the Asian Pacific Society of Respirology·Grant WatererRichard Wunderink